Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

-Ahead of print
-Authors' Accepted
    Manuscripts
new!
-Current Issue
-Archive
-Acknowledgments
-Special Issues
-Browse by Category

Manuscript Submission

-Online Submission
-Online Review
-Instruction for Authors
-Instruction for Reviewers
-English Corner new!

About AJA

-About AJA
-Editorial Board
-Contact Us
-News

Resources & Services

-Advertisement
-Subscription
-Email alert
-Proceedings
-Reprints

Download area

-Copyright licence
-EndNote style file
-Manuscript word template
-Guidance for AJA figures
    preparation (in English)

-Guidance for AJA figures
    preparation (in Chinese)

-Proof-reading for the
    authors

-AJA Club (in English)
-AJA Club (in Chinese)

 
Abstract

Volume 16, Issue 5 (September 2014) 16, 725–727; 10.4103/1008-682X.128467

Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation

Abdulmuttalip Simsek1, Sinan Levent Kirecci2, Onur Kucuktopcu1, Faruk Ozgor1, Mehmet Fatih Akbulut1, Omer Sarilar1, Unsal Ozkuvanci1, Zafer Gokhan Gurbuz1

1Department of Urology, Haseki Research and Training Hospital, Fatih, Istanbul, 2Department of Urology, Sisli Etfal Research and Training Hospital, Istanbul, Turkey.

Correspondence: Dr. A Simsek (simsek76@yahoo.com)

Received: 26 October 2013; Revised: 18 November 2013; Accepted: 20 February 2014

Abstract

Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on‑demand treatment of premature ejaculation (PE). Our objective in this study was to characterize the efficacy of on‑demand dapoxetine (30 and 60 mg) and daily paroxetine (20 mg) usage in treating PE. We conducted a 1 month study involving a total of 150 patients. Patients were divided into three groups of 50. Group 1 were treated with on‑demand dapoxetine (30 mg), Group 2 with on‑demand dapoxetine (60 mg) and Group 3 with daily paroxetine (20 mg). Our outcome measurement was increased from baseline intravaginal ejaculatory latency time (IELT) after treatment. The IELT increased from baseline to posttreatment by 117%, 117% and 170% in the paroxetine group (P < 0.01), 30 mg dapoxetine group ( 0.01) and 60 mg dapoxetine group ( 0.01), respectively. The increase from baseline IELT were similar for the 30 mg dapoxetine and paroxetine groups (P > 0.05), while the 60 mg dapoxetine group had a larger posttreatment IELT increase compared with the 30 mg dapoxetine ( 0.05) and paroxetine ( 0.01) groups. Dapoxetine (60 mg) 1–3 h before planned intercourse is a very effective treatment modality for PE. However, an on‑demand dose of 30 mg dapoxetine is no more effective than the currently prescribed paroxetine treatment.

Keywords: dapoxetine; paroxetine; premature ejaculation; selective serotonin reuptake inhibitor

Full Text | PDF | 中文摘要 |

 
Browse:  2951
 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.